Gliomatosis cerebri classification

	Gliomatosis cerebri Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Gliomatosis cerebri from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Gliomatosis cerebri classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Gliomatosis cerebri classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Gliomatosis cerebri classification
CDC on Gliomatosis cerebri classification
Gliomatosis cerebri classification in the news
Blogs on Gliomatosis cerebri classification
Directions to Hospitals Treating Gliomatosis cerebri
Risk calculators and risk factors for Gliomatosis cerebri classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Gliomatosis cerebri may be classified into several subtypes based on the origin (primary and secondary) and the type of tumor cell (astrocytic, oligodendroglial, and mixed).

Classification

Based on the origin

Gliomatosis cerebri may be classified based on the origin into two subtypes:^[1]^[2]^[3]^[4]


Type of gliomatosis cerebri	Characteristic features

Type 1 (Primary)	No pre-existing primary cerebral neoplastic lesion (de novo) No discrete mass Diffuse spread of tumor More common Median age at diagnosis is 56 years Mean survival time was longer than type 2 (24 months) Predominantly low-grade
Type 2 (Secondary)	Results from a pre-existing cerebral glioma Discrete mass with diffuse CNS involvement Less common Median age at diagnosis is 44 years Mean survival time was shorter than type 1 (21 months) Predominantly high-grade IDH1 mutation is more common

Based on the type of tumor cell

Gliomatosis cerebri may be classified based on the predominant tumor cell type into three sub-types:^[4]

Astrocytic - it is considered a distinct entity of astrocytic glioma as per the latest WHO classification for CNS tumors.^[5]

Oligodendroglial - very few cases of isolated oligodendroglial GC has been reported. No difference in the signs and symptoms are noted.^[6]
Mixed - more common than isolated oligodendroglial GC.

References

↑ Classification of gliomatosis cerebri. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/gliomatosis-cerebri
↑ Brandão RA, de Carvalho GT, de Azeredo Coutinho CA, Christo PP, Santiago CF, Santos Mdo C; et al. (2011). "Gliomatosis cerebri: diagnostic considerations in three cases". Neurol India. 59 (1): 122–5. doi:10.4103/0028-3886.76892. PMID 21339680.
↑ Park S, Suh YL, Nam DH, Kim ST (2009). "Gliomatosis cerebri: clinicopathologic study of 33 cases and comparison of mass forming and diffuse types". Clin Neuropathol. 28 (2): 73–82. PMID 19353837.
↑ ^4.0 ^4.1 Sanson M, Cartalat-Carel S, Taillibert S, Napolitano M, Djafari L, Cougnard J; et al. (2004). "Initial chemotherapy in gliomatosis cerebri". Neurology. 63 (2): 270–5. PMID 15277619.
↑ "Gliomatosis cerebri: no evidence for a separate brain tumor entity".
↑ "Oligodendroglial gliomatosis cerebri".

Template:WikiDoc Sources

[aaa-1] Classification of gliomatosis cerebri. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/gliomatosis-cerebri

[pmid21339680-2] Brandão RA, de Carvalho GT, de Azeredo Coutinho CA, Christo PP, Santiago CF, Santos Mdo C; et al. (2011). "Gliomatosis cerebri: diagnostic considerations in three cases". Neurol India. 59 (1): 122–5. doi:10.4103/0028-3886.76892. PMID 21339680.

[pmid19353837-3] Park S, Suh YL, Nam DH, Kim ST (2009). "Gliomatosis cerebri: clinicopathologic study of 33 cases and comparison of mass forming and diffuse types". Clin Neuropathol. 28 (2): 73–82. PMID 19353837.

[pmid15277619-4] 4.0 ^4.1 Sanson M, Cartalat-Carel S, Taillibert S, Napolitano M, Djafari L, Cougnard J; et al. (2004). "Initial chemotherapy in gliomatosis cerebri". Neurology. 63 (2): 270–5. PMID 15277619.

[5] "Gliomatosis cerebri: no evidence for a separate brain tumor entity".

[6] "Oligodendroglial gliomatosis cerebri".

[1]

[2]

[3]

[4]

[5]

[6]